Madison Muller

Stay informed with Madison Muller’s coverage and analysis for Fortune.

  • Eli Lilly's headquarters sits behind a gate with the US flag raisedFinance

    Eli Lilly to spend $27 billion to bolster U.S. drug manufacturing as Trump tariffs loom

    By Madison Muller and Bloomberg
  • Semaglutide medications Wegovy and Ozempic are picturedHealth

    Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers

    By Bloomberg, Madison Muller, and others
  • A hand is seen holding Ozempic.Health

    Novo’s main Ozempic plant cited for quality lapses by FDA

    By Madison Muller and Bloomberg
  • Sen. Bernie Sanders is seen pointing and speaking at the opening of a Senate committee hearing.Politics

    Bernie Sanders grills Ozempic maker over high prices, accuses company of endangering lives

    By Madison Muller, Naomi Kresge, and others
  • A doctor holds a package of the drug Ozempic. The logo is clearly visible and there is a visual of the product on the box.Finance

    Ozempic ‘very likely’ to have price slashed in US government negotiations

    By Gerry Smith, Madison Muller, and others
  • A photo of the packet for anti-obesity drug Wegovy.Health

    Wegovy reduced Covid deaths in obese patients, study finds

    By Madison Muller and Bloomberg
  • INDIANAPOLIS, INDIANA – MARCH 17: A flag flies above the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. Lilly, a pharmaceutical company, employs more than 12.000 people in Indianapolis and more than 42,000 worldwide. (Photo by Scott Olson/Getty Images)Health

    Lilly wins FDA approval for new drug to slow Alzheimer’s

    By Madison Muller, Robert Langreth, and others
  • woman shows off old oversized jeansHealth

    Hims will follow its Viagra playbook and offer weight-loss drugs that are 85% cheaper than Wegovy—with Mounjaro and Zepbound in its sights next

    By Madison Muller, Jessica Nix, and others
  • INDIANAPOLIS, INDIANA – MARCH 17: A flag flies above the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. Lilly, a pharmaceutical company, employs more than 12.000 people in Indianapolis and more than 42,000 worldwide. (Photo by Scott Olson/Getty Images)Health

    Demand for weight-loss drug Zepbound is so strong that Eli Lilly is warning patients may leave pharmacies empty-handed

    By Ike Swetlitz, Madison Muller, and others
  • Bernie SandersPolitics

    ‘Outrageous’: Bernie Sanders has Ozempic demands after study says it costs just $5 per month to manufacture

    By Madison Muller, Robert Langreth, and others
  • CEO of Novo Nordisk Lars Fruergaard Jorgensen is seen during the 6th edition of the “Choose France” Summit at the Chateau de Versailles, outside Paris on May 15, 2023. Since 2018, the Choose France Summit seeks to promote France’s economic attractiveness and encourage international investment across the country and brings together hundreds of leaders from the largest multinational corporations. (Photo by Ludovic MARIN / POOL / AFP) (Photo by LUDOVIC MARIN/POOL/AFP via Getty Images)Health

    Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5

    By Madison Muller, Robert Langreth, and others
  • A man walking in front of SweetgreenRetail

    Meet the surprise winner of the Ozempic craze: a fast-casual chain selling $18 salads

    By Madison Muller and Bloomberg
  • Patients given a monthly injection of Amgen’s drug, dubbed MariTide, lost up to 14.5% of their body weight in just 12 weeks, according to a small, early-stage study published Monday in the journal Nature Metabolism.Health

    Experimental once-a-month weight loss injectable shows lasting results in early study

    By Madison Muller and Bloomberg
  • The last time there was this much hype over a new drug was for Viagra, which was approved in 1998. Yet hurdles remain, when it comes to the ability of patients to access weight loss and anti-diabetes injectables like Zepbound and Wegovy: These drugs cost a lot, insurance coverage is spotty, and patients may need to take them indefinitely to avoid regaining weight.Health

    Weight-loss injectables like Zepbound are making as big of a splash as Viagra, if not bigger. What you need to know about the ‘miracle drugs’

    By Emma Court, Madison Muller, and others
  • Novo Nordisk A/S Ozempic brand semaglutide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023. Prescriptions of appetite suppressing GLP-1 weight-loss drugs skyrocketed 300% from 2020 to 2022. Photographer: George Frey/Bloomberg via Getty ImagesHealth

    North Carolina drops coverage for Wegovy and Ozempic, with implications for anti-obesity drug market projected to hit $100B by 2030

    By Simone Foxman, Madison Muller, and others